Compass sees 'good' start to the year
Food and support services firm Compass says that is has had a good first quarter and its expectations for the full-year remain unchanged, despite experiencing a continuing challenging macroeconomic environment in Europe.
Food and support services firm Compass says that is has had a good first quarter and its expectations for the full-year remain unchanged, despite experiencing a continuing challenging macroeconomic environment in Europe.
Nevertheless, the group said that like-for-like volumes in North American and the Fast Growing & Emerging Markets continue to be robust.
Excluding the one-off impact of a players' strike in the National Basketball Association in the US (which cut organic revenue growth by 1%), group organic revenues rose by almost 5% in the first quarter. Including the impact of acquisition, overall revenues rose over 8% on a constant currency basis.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
"We have seen good levels of new business wins and the improved level of retention we achieved in the second half of last year has continued into the new financial year," Compass said.
BC
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
What the Employment Rights Bill means for your job
New workplace reforms are set to give employees new rights to benefits and flexible working
By Marc Shoffman Published
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published